SAFE vs. Convertible Notes: Which is a Better Choice for Early-Stage Investments?

Experienced early-stage investors are familiar with convertible note investments, which have evolved slightly but have been around in largely the same form for more than two decades. Convertible note investments start...

Solenic CEO James Lancaster presents at the LSI Emerging Medtech Summit

Leaders in the MedTech market gather at the global Emerging Medtech Summit event, filled with industry-leading innovators, investors, and strategics. During the event, Solenic Medical CEO James Lancaster shares how...

From the Corner Office: Neurexis Therapeutics

Let me start by saying that the last two years have been a case study on focusing on priorities and filtering out noise. I’m fortunate to work in an area where it’s easy to see the long-term value of what we...

Inside CSURF with Managing Director, Steve Foster

Please describe your background After my undergrad in Biological Sciences, I spent 13 years at Amgen in Thousand Oaks, CA. After 11 years in the lab, I wanted to try something different and ended up in the Corporate...

Filtravate Highlighted by The Business Journals

A Las Cruces startup developing a production process for tunable water filters is raising its seed funding round. The startup, Filtravate, utilizes technology licensed from New Mexico State University. Angel investors...

VIC Fellows Spotlight: Gurshagan Kandhola, PhD

The VIC Fellows Program provides an opportunity for individuals with relevant expertise and interest to learn how to identify and evaluate promising innovation from global sources. We are pleased to highlight the...

VIC 2021 Annual Report Executive Summary

2021 was a highly productive year for VIC and our portfolio companies. Click Here to download the Annual Report Executive Summary or view it below.

VIC Technology Venture Development Establishes Medical Advisory Board

VIC’s newly formed Medical Advisory Board (MAB) provides VIC with additional domain expertise across a variety of life science disciplines. MAB members support VIC’s opportunity assessment team by reviewing new...

Letter from the CEO

It has been a year and ten months since the World Health Organization declared COVID-19 a pandemic. Despite the continuing pandemic, VIC’s business has largely returned to normal albeit with increased remote work, more...

Investing in Medical Devices & Diagnostics – Industry Trends and Investor Activity

Recently, the medical device and diagnostics sectors have seen considerable disruption. Common medical devices used in disease detection and treatment, for example, imaging systems such as X-ray and MRI machines, CT-...

FEATURED RESOURCES

Updates
VIC Tech Announces New Class of Fellows
Insight
Women Shaping Life Sciences: Laura Lyons on Purpose, Perseverance, and Patient-Centered Innovation
White Paper
Fostering Life Science Innovation: Part 2 – Inventing with the End in Mind
Interview
Inside the Office of Technology Commercialization at the University of Kentucky with Holly Clark, PhD, Senior Commercialization Manager
Insight
Seven Reasons Venture Capital-Stage Companies Should Become Part of Your Investment Portfolio
White Paper
Fostering Life Science Innovation: Part 1 – An Ecosystem Roadmap
News
SFC Fluidics Collaborating with Duracell to Power Innovative Diabetes Devices
Interview
VIC Fellows Spotlight: Nicole Shirkey-Son, PhD
From The Corner Office
From the Corner Office with Enhance Diagnostics